Boosters give over 90% protection against symptomatic COVID-19 in adults over 50

These findings show that 2 weeks after receiving a booster dose, protection against symptomatic infection in adults aged 50 years and over was 93.1% in those with AstraZeneca as their primary course and 94.0% for Pfizer-BioNTech.

Read full article